Compounding facility ProRx Pharmacy Network has received an FDA warning letter over issues with its semaglutide and ...
FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...
The Food and Drug Administration said Thursday it’s standing by its earlier decision that the shortage of tirzepatide ... the CEO of Alliance for Pharmacy Compounding, another trade group ...